Multiple loci comprising immune-related genes regulate experimental neuroinflammation

Genes and Immunity

Volumn 11, Issue 1, 2010, Pages 21-36

  Marta, M ^a,b   Stridh, P ^a   Becanovic, K ^a   Gillett, A ^a   Ockinger J ^a   Lorentzen, J C ^a   Jagodic, M ^a   Olsson, T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmunity; EAE MS; Gene regulation; Neuroimmunology; Rodent

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADVANCED INTERCROSS LINE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CHROMOSOME 4; CONTROLLED STUDY; DISEASE SEVERITY; EPISTASIS; FEMALE; GENETIC SUSCEPTIBILITY; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; LINKAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; RAT; RECOMBINANT CONGENIC STRAIN;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MYELIN-ASSOCIATED GLYCOPROTEIN; QUANTITATIVE TRAIT LOCI; RATS;

RATTUS; RODENTIA;

EID: 75049084092     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.62     Document Type: Article

References (66)

1. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 11-15.
2. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian collaborative study group. Nature 1995; 377: 150-151.
3. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The canadian collaborative study group. Lancet 1996; 347: 1728-1730.
4. Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-1112.
5. Abdeen H, Heggarty S, Hawkins SA, Hutchinson M, McDonnell GV, Graham CA. Mapping candidate non-MHC susceptibility regions to multiple sclerosis. Genes Immun 2006; 7: 494-502.
6. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113.
7. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
8. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
9. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M et al. Autoimmunity to myelin oligoden-drocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8: 681-694.
10. Weissert R, Wallstrom E, Storch MK, Stefferl A, Lorentzen J, Lassmann H et al. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 1998; 102: 1265-1273.
11. Becanovic K, Wallstrom E, Kornek B, Glaser A, Broman KW, Dahlman I et al. New loci regulating rat myelin oligo-dendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 2003; 170: 1062-1069.
12. Dahlman I, Jacobsson L, Glaser A, Lorentzen JC, Andersson M, Luthman H et al. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J Immunol 1999; 162: 2581-2588. (Pubitemid 29309277)
13. Dahlman I, Wallstrom E, Weissert R, Storch M, Kornek B, Jacobsson L et al. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalo-myelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet 1999; 8: 2183-2190. (Pubitemid 29525332)
14. Roth MP, Viratelle C, Dolbois L, Delverdier M, Borot N, Pelletier L et al. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalo-myelitis on rat chromosomes 4 and 10. J Immunol 1999; 162: 1917-1922.
15. Dahlman I, Lorentzen JC, de Graaf KL, Stefferl A, Linington C, Luthman H et al. Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycopro-tein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur J Immunol 1998; 28: 2188-2196.
16. Becanovic K, Backdahl L, Wallstrom E, Aboul-Enein F, Lassmann H, Olsson T et al. Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats. Eur J Immunol 2003; 33: 1907-1916.
17. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95: 9979-9984.
18. Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes. Curr Opin Immunol 2000; 12: 691-697.
19. Jagodic M, Marta M, Becanovic K, Sheng JR, Nohra R, Olsson T et al. Resolution of a 16.8 Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait Loci and evidence for epistasis. J Immunol 2005; 174: 918-924.
20. Ockinger J, Serrano-Fernandez P, Moller S, Ibrahim SM, Olsson T, Jagodic M. Definition of a 1.06 Mb region linked to neuroinflammation in humans, rats and mice. Genetics 2006; 173: 1539-1545.
21. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005; 37: 486-494.
22. Jagodic M, Becanovic K, Sheng JR, Wu X, Backdahl L, Lorentzen JC et al. An advanced intercross line resolves eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J Immunol 2004; 173: 1366-1373.
23. Backdahl L, Ribbhammar U, Lorentzen JC. Mapping and functional characterization of rat chromosome 4 regions that regulate arthritis models and phenotypes in congenic strains. Arthritis Rheum 2003; 48: 551-559.
24. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 4349-4356.
25. Encinas JA, Lees MB, Sobel RA, Symonowicz C, Weiner HL, Seidman CE et al. Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int Immunol 2001; 13: 257-264.
26. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293.
27. Jacob HJ, Brown DM, Bunker RK, Daly MJ, Dzau VJ, Goodman A et al. A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet 1995; 9: 63-69.
28. Sen S, Churchill GA. A statistical framework for quantitative trait mapping. Genetics 2001; 159: 371-387.
29. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003; 19: 889-890.
30. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994; 138: 963-971.
31. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
32. Lander ES, Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989; 121: 185-199.
33. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination [see comments]. Ann Neurol 2000; 47: 707-717.
34. Prineas JW, Graham JS. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 1981; 10: 149-158.
35. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination. Ann Neurol 1998; 43: 465-471.
36. Raine CS, Cannella B, Hauser SL, Genain CP. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann Neurol 1999; 46: 144-160.
37. Lassmann H, Brunner C, Bradl M, Linington C. Experimental allergic encephalomyelitis: the balance between encephalito-genic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathologica 1988; 75: 566-576.
38. Subramanian S, Wakeland EK. The importance of epistatic interactions in the development of autoimmunity. Novartis Found Symp 2005; 267: 76-88; discussion 88-93.
39. Wandstrat AE, Nguyen C, Limaye N, Chan AY, Subramanian S, Tian XH et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004; 21: 769-780.
40. Kong PL, Morel L, Croker BP, Craft J. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. J Immunol 2004; 172: 2785-2794.
41. Pandey JP, Prohaszka Z, Veres A, Fust G, Hurme M. Epistatic effects of genes encoding immunoglobulin GM allotypes and interleukin-6 on the production of autoantibodies to 60-and 65-kDa heat-shock proteins. Genes Immun 2004; 5: 68-71.
42. Mix E, Ibrahim S, Pahnke J, Koczan D, Sina C, Bottcher T et al. Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process. J Neuro-immunol 2004; 151: 158-170.
43. Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E et al. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J Immunol 2006; 176: 6055-6064.
44. Herrera BM, Cader MZ, Dyment DA, Bell JT, Ramagopalan SV, Lincoln MR et al. Follow-up investigation of 12 proposed linkage regions in multiple sclerosis. Genes Immun 2006; 7: 366-371.
45. Togni M, Swanson KD, Reimann S, Kliche S, Pearce AC, Simeoni L et al. Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM. Mol Cell Biol 2005; 25: 8052-8063.
46. Deng C, Minguela A, Hussain RZ, Lovett-Racke AE, Radu C, Ward ES et al. Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis. J Immunol 2002; 168: 4511-4518.
47. Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N et al. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of auto-reactive Th1 responses in vivo. J Immunol 2003; 171: 3451-3458.
48. Rinker 2nd JR, Trinkaus K, Cross AH. Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology 2006; 67: 1288-1290.
49. Abiola O, Angel JM, Avner P, Bachmanov AA, Belknap JK, Bennett B et al. The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet 2003; 4: 911-916.
50. Li J, Gran B, Zhang GX, Ventura ES, Siglienti I, Rostami A et al. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J Neurol Sci 2003; 215: 95-103.
51. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463.
52. Roos IM, Kockum I, Hillert J. The interleukin 23 receptor gene in multiple sclerosis: a case-control study. J Neuroimmunol 2008; 194: 173-180.
53. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM et al. The N-terminal domain of the myelin oligodendro-cyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995; 63: 17-27.
54. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M et al. Antibody facilitation of multiple sclerosislike lesions in a nonhuman primate. J Clin Invest 1995; 96: 2966-2974.
55. Gracie JA, Bradley JA. Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass. Eur J Immunol 1996; 26: 1217-1221.
56. Saoudi A, Kuhn J, Huygen K, de Kozak Y, Velu T, Goldman M et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 1993; 23: 3096-3103.
57. Martin AM, Blankenhorn EP, Maxson MN, Zhao M, Leif J, Mordes JP et al. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes 1999; 48: 50-58.
58. Martin AM, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP. Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a 'universal autoimmunity locus' on rat chromosome 4. Diabetes 1999; 48: 2138-2144.
59. Mordes JP, Cort L, Norowski E, Leif J, Fuller JM, Lernmark A et al. Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: identification of a susceptibility haplotype in the Tcrb-V locus. Mamm Genome 2009; 20: 162-169.
60. Blankenhorn EP, Descipio C, Rodemich L, Cort L, Leif JH, Greiner DL et al. Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene. Ann N Y Acad Sci 2007; 1103: 128-131.
61. Kawahito Y, Cannon GW, Gulko PS, Remmers EF, Longman RE, Reese VR et al. Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases [In Process Citation]. J Immunol 1998; 161: 4411-4419.
62. Joe B. Quest for arthritis-causative genetic factors in the rat. Physiol Genomics 2006; 27: 1-11.
63. Remmers EF, Longman RE, Du Y, OH A, Cannon GW, Griffiths MM et al. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet 1996; 14: 82-85.
64. Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, Pettersson U et al. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 1998; 20: 401-404.
65. Wilder RL, Griffiths MM, Remmers EF, Cannon GW, Caspi RR, Kawahito Y et al. Localization in rats of genetic loci regulating susceptibility to experimental erosive arthritis and related autoimmune diseases. Transplant Proc 1999; 31: 1585-1588.
66. Sun SH, Silver PB, Caspi RR, Du Y, Chan CC, Wilder RL et al. Identification of genomic regions controlling experimental autoimmune uveoretinitis in rats. Int Immunol 1999; 11: 529-534.